60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
5
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. 60 Degrees Pharmaceuticals Inc market cap is $2.4M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. 60 Degrees Pharmaceuticals Inc 52 week high is $8.62 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. 60 Degrees Pharmaceuticals Inc 52 week low is $0.4601 as of November 18, 2026.
60 Degrees Pharmaceuticals Inc stock price today is $0.5379.
60 Degrees Pharmaceuticals Inc stock price yesterday was $0.5341.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. 60 Degrees Pharmaceuticals Inc's P/E ratio is -0.09.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. 60 Degrees Pharmaceuticals Inc P/B ratio is -0.2043.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. 60 Degrees Pharmaceuticals Inc 50-day moving average is $0.9238.